Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Preclinical data on the safety of the antithrombotic drug W215A/E217A reported

Dec. 22, 2006

Japanese scientists report on the activity of moAb-216

Dec. 21, 2006

Sankyo patents novel antiplatelet agents

Dec. 20, 2006

ZymoGenetics seeks FDA approval for rhThrombin

Dec. 19, 2006

AKR-501 increases platelet counts in healthy subjects

Dec. 15, 2006

Otsuka and Chugai to copromote Pletaal in Japan

Dec. 14, 2006

ART-123 superior to heparin in disseminated intravascular coagulation

Dec. 14, 2006

Phase III trials of alfimeprase in PAO and catheter occlusion fail to meet endpoints

Dec. 13, 2006

Idraparinux shows encouraging results in patients at high risk of thromboembolism

Dec. 13, 2006

Fibrin Patch begins clinical studies

Dec. 13, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....